Education
About Us
Working with TipRanks
Follow Us
Fonar Corp (FONR)
NASDAQ:FONR
FONR Stock Chart & Stats
$14.07
<$0.01(0.05%)
At close: 4:00 PM EST
$14.07
<$0.01(0.05%)
Day’s Range― - ―
52-Week Range$12.00 - $18.86
Previous CloseN/A
Volume3.43K
Average Volume (3M)29.06K
Market Cap
$116.61M
Enterprise Value$100.96M
Total Cash (Recent Filing)$53.10M
Total Debt (Recent Filing)$39.80M
Price to Earnings (P/E)14.2
Beta0.20
Next Earnings
May 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.31
Shares Outstanding6,173,008
10 Day Avg. Volume24,606
30 Day Avg. Volume29,056
Financial Highlights & Ratios
PEG Ratio-0.59
Price to Book (P/B)0.55
Price to Sales (P/S)0.91
P/FCF Ratio12.69
Enterprise Value/Market Cap0.87
Enterprise Value/Revenue0.95
Enterprise Value/Gross Profit2.33
Enterprise Value/Ebitda6.17
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Recurring Diagnostic Imaging Services ModelFonar’s core revenue comes from operating MRI centers and delivering scans, a recurring service tied to referral relationships, payer billing and collections. This service-based model provides more predictable cash flow than one-off product sales and supports steady operating income over time.
Conservative Balance Sheet With Low LeverageReported debt-to-equity near 0.22–0.25 and steadily building equity indicate low financial leverage. That conservative capital structure supports resilience through revenue softness, preserves strategic flexibility for capex or restructuring, and reduces solvency risk over the medium term.
Insider-led Take-private AgreementAn insider-led merger to take the company private aligns management and owners and can enable longer-term restructuring away from quarterly public scrutiny. If completed, this could allow focused investment or reorganization of the loss-making equipment segment and streamline decision-making.
Bears Say
Sharp TTM Revenue DeclineA roughly 22% TTM revenue decline is a durable headwind that reduces operating scale and limits fixed-cost absorption. Lower top-line momentum pressures margins, curtails reinvestment capacity in centers or technology, and weakens the company’s ability to execute growth initiatives over the coming quarters.
Weakened Cash Conversion And Free Cash FlowOperating cash flow covering only ~64% of earnings and FCF at ~62%—with FCF down ~24% TTM—indicate deteriorating cash quality. Persistent lower cash conversion constrains capital spending, debt service flexibility, and the ability to fund network upkeep or absorb payer/reimbursement pressure over the medium term.
Loss-making MRI Equipment SegmentThe legacy MRI equipment business is loss-making while imaging centers supply operating income. A continued unprofitable equipment segment drags consolidated margins, diverts management focus and capital, and increases earnings volatility unless addressed through restructuring or strategic exits.
Fonar News
FONR FAQ
What was Fonar Corp’s price range in the past 12 months?
Fonar Corp lowest stock price was $12.00 and its highest was $18.86 in the past 12 months.
What is Fonar Corp’s market cap?
Fonar Corp’s market cap is $116.61M.
When is Fonar Corp’s upcoming earnings report date?
Fonar Corp’s upcoming earnings report date is May 18, 2026 which is in 72 days.
How were Fonar Corp’s earnings last quarter?
Fonar Corp released its earnings results on Feb 13, 2026. The company reported $0.306 earnings per share for the quarter, beating the consensus estimate of N/A by $0.306.
Is Fonar Corp overvalued?
According to Wall Street analysts Fonar Corp’s price is currently Overvalued.
Does Fonar Corp pay dividends?
Fonar Corp does not currently pay dividends.
What is Fonar Corp’s EPS estimate?
Fonar Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fonar Corp have?
Fonar Corp has 6,173,008 shares outstanding.
What happened to Fonar Corp’s price movement after its last earnings report?
Fonar Corp reported an EPS of $0.306 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Fonar Corp?
Currently, no hedge funds are holding shares in FONR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Fonar Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-1.84%
12-Months-Change
Fundamentals
Return on Equity
4.34%
Trailing 12-Months
Asset Growth
2.86%
Trailing 12-Months
Company Description
Fonar Corp
Fonar Corporation (FONR) is a medical technology company focused on the development and manufacturing of advanced magnetic resonance imaging (MRI) systems. The company operates primarily in the healthcare sector, providing innovative imaging solutions that enhance diagnostic capabilities for medical professionals. Fonar's core products include its patented upright MRI systems, which allow patients to be scanned in weight-bearing positions, resulting in improved diagnostic accuracy and patient comfort.
Technical Analysis
Xtant Medical Holdings
―
Varex Imaging
―
Viemed Healthcare
―
Nano-X Imaging
―
Cytek Biosciences
―
Ownership Overview
―
Insiders
11.87% Mutual Funds
18.66% Other Institutional Investors
61.77% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---